Skip to content

Neural Basis of Cognition

Studying Human Cognition and Neurological Disorders Using µECoG Electrodes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05132543
Enrollment
38
Registered
2021-11-24
Start date
2026-09-01
Completion date
2027-09-15
Last updated
2026-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

The overall purpose of this study is to better understand human cognition and human epilepsy by working with patients undergoing clinical treatment for pharmacologically resistant epilepsy. The investigators will investigate human cognition by conducting controlled experiments that focus on sensory, motor, and cognitive phenomena such as sensory processing, memory, and language. The investigators will also examine the neural underpinnings of epilepsy during both sleep and wakefulness to better understand both the foundations of epilepsy and how epilepsy affects cognition. The investigators hope to use these data to have a better understanding of cognition, epilepsy, and how the two interact. This will potentially lead to better markers for seizure onsets as well as epilepsy more generally. For this research, the investigators will use μECoG arrays manufactured by commercial partners. These arrays have passed all major ISO 10993 bio-compatibility tests. Based on this characterization and use in the intraoperative setting (limited duration and supervised usage), these devices pose a minimal risk to participants. Data will be analyzed and protected using the Duke SSRI protected research data network.

Interventions

DEVICEHigh density micro-electrocorticography for neural speech prothesis

ECoG electrodes are thin, high-density, flexible electrode arrays used for recording electrophysiological signals from the brain.

Sponsors

Duke University
Lead SponsorOTHER
National Institute on Deafness and Other Communication Disorders (NIDCD)
CollaboratorNIH

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Potential subjects will come from adult and pediatric patients (between the ages of 12 and 18) undergoing surgery for the treatment of pharmacologically resistant epilepsy, brain tumor resection, brain mass resection, or deep brain stimulation (DBS) for the first time * Proficient English speakers * No Major cognitive impairment

Exclusion criteria

* Previous DBS procedure * Subject unable to consent to study

Design outcomes

Primary

MeasureTime frameDescription
Evoked signal-to-noise analysis human brain.Intraoperative data collection period, 20 minutesThis study will compare the neural response sensitivity of intraoperative µECoG recording to those of in-unit recordings with macro-ECoG and SEEG. The strength and reliability of the high gamma (HG) response are critical for speech decoding algorithms. For all recordings, the HG power modulation ratio over baseline during speech perception and production will be measured and compared with non-parametric statistical tests.
Percentage of phoneme decoding accuracy as measured by linear decoding modelIntraoperative data collection period, 20 minutes
Number of HG power modulation as measured by signal power.Intraoperative data collection period, 20 minutes
Number of kriging resolution as measured by signal power.Intraoperative data collection period, 20 minutes

Secondary

MeasureTime frame
Number of serious adverse events as measured by medical record reviewImplantation to Three-months follow-up

Contacts

CONTACTGregory B Cogan, PhD
gregory.cogan@duke.edu919-681-7601
CONTACTJessica Carlson
jessica.carlson@duke.edu(919)668-2841
PRINCIPAL_INVESTIGATORGregory B Cogan, PhD

Duke University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 18, 2026